Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Multiple Sclerosis, Relapsing-Remitting
Clinical Trial
NCT02545868Last updated: 1/15/2026
ROCHE
Roche Holding AG